TLR4 and bacterial infectious disease: In the context of bacterial diseases, miR-17-5p has been shown to down-regulate lipopolysaccharide (LPS)-induced Toll-like-receptor 4 (TLR4)-mediated inflammation [64,65], thus favoring a balanced immune response.